SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
FORM 8-K
_________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
January 29, 2020
_________________________________________________
SCIENTIFIC INDUSTRIES, INC.
_________________________________________________
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
000-6658
|
|
04-2217279
|
|
(State
or other Jurisdiction)
|
|
(Commission
File Number)
|
|
(IRS
Employer No.)
|
80 Orville Drive
Bohemia, New York 11716
__________________________________________________
(Address
of principal executive offices)
(631) 567-4700
__________________________________________________
(Registrant's
telephone number, including area code)
Not Applicable
__________________________________________________
(Former
name or former address, if changed since last report)
ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY
ARRANGEMENTS OF CERTAIN OFFICERS
On January 29, 2020, the Board of Directors of the Company
appointed John Moore as its Chairman of the Board and Joseph
Cremonese as its Chairman Emeritus. Mr. Moore, age 54, was
appointed a Class B director on January 23, 2019 and re elected at
the Company’s 2019 Annual Meeting to serve until the
Company’s Annual Meeting of Stockholders with respect to the
year ending June 30, 2022.
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY
HOLDERS
At the Annual Meeting of Stockholders of the Company held on
January 29, 2020, the stockholders took the following
actions:
1. Elected Mr. Marcus Frampton and Mr. John Moore as Class B
Directors to serve until the Annual Meeting of Stockholders for the
year ended June 30, 2022 by the following votes:
|
|
For
|
Withheld
|
|
Marcus
Frampton
|
762,420
|
90,815
|
|
John
Moore
|
762,420
|
90,815
|
2. Approved by a vote of 766,863 shares for, 2,245 shares against,
and 83,127 shares abstaining, the amendment to the Company’s
2012 Stock Option Plan to
increase the number of shares available for issuance thereunder by
150,000 shares, from 157,000 to 307,000 shares.
3. Approved by a vote of 1,116,329 shares for, no shares against,
and 152 shares abstaining, the appointment by the Board of
Directors of Nussbaum Berg Klein & Wolpow CPAs LLP as the
Company's independent registered public accounting firm with
respect to the Company's financial statements for the year ending
June 30, 2020.
1
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
SCIENTIFIC INDUSTRIES, INC.
|
||
|
|
|
|
|
|
|
|
|
|
|
Date: February 10, 2020
|
By:
|
/s/ Helena R. Santos
|
|
|
|
|
Helena R. Santos,
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
|
2